The Chinese subsidiary of Haikui Seafood AG has successfully signed an agreement regarding the acquisition of land use rights with the local authorities in Dongshan, paving the way for the construction of its new production site. The ...
Tags: Land Use Agreement, Haikui Seafood
Foster Wheeler AG (Nasdaq:FWLT) (“Foster Wheeler” or the “Company”) today confirmed that, following a comprehensive review of strategic alternatives, it has provisionally agreed with AMEC plc (“AMEC”) on ...
Tags: Foster Wheeler, AMEC, non-binding outline terms, business combination
Can changes to a cow's energy intake during the second trimester enhance the quality of beef her offspring will produce? What effect might it have on the reproductive ability of the cow's offspring? Those are questions a team of SDSU ...
Tags: beef industry, cow's offspring, cow, energy intake, second trimester
Scientists led by experts at Durham University have discovered a natural mechanism in plants that could stimulate their growth even under stress and potentially lead to better crop yields. Plants naturally slow their growth or even stop ...
Tags: plants, better crop yields, plants growth, stimulate, Gibberellin
Z Trim Holdings, Inc., a biotechnology company providing value-added ingredients to a variety of industries, today announced that it recorded, for the 4th quarter of 2013, $387,006 in sales which is a 76% increase over $220,433 in the 4th ...
Tags: dairy, salad dressings, sauces
This is a guest post. The views expressed here are solely those of the author and do not represent positions of IEEE Spectrum or the IEEE. Two years ago, New York Times columnist Paul Krugman wrote a much-discussed piece on the ...
Tags: Robotics Industry, Robot
Scientists at The University of Nottingham are leading the world in exploiting MRI technology to assist in the treatment and diagnosis of Irritable Bowel Syndrome (IBS), a condition that causes serious inconvenience and discomfort to ...
Tags: MRI technology, Irritable Bowel Syndrome, University of Nottingham
Illumina, Inc. (NASDAQ:ILMN) today announced it has entered into a multi-year licensing agreement with Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, related to the use of Illumina's ...
Tags: Illumina, multi-year licensing agreement, Quest Diagnostics
IBM is spending $1 billion to give Watson its own New York City–based business division as it seeks commercial applications for its Jeopardy-winning supercomputer in healthcare and other fields. But will medical companies truly find a ...
Tags: IBM, Computer Products
Monsanto Company's (NYSE: MON) annual research and development update marks the company's largest advancement of products to date. The agricultural company announced today a record 29 products progressed in its pipeline with five of those ...
Tags: Annual Product, Monsanto
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced that it has entered into an oncology research collaboration and licensing agreement with ...
Tags: Immunocore, oncology research, collaboration and licensing agreement
Dietary supplements may upset the balance in the body's cells and therefore cause more harm than good, according to new research from Norway. The study, which is being conducted by a research group at the Biotechnology Centre at the ...
Tags: Agriculture, Food
U.S. corn exports to Latin America continue to grow. According to the USDA, the Western Hemisphere's accumulated U.S. corn imports are more than 67 million bushels ahead of last year at this same time. Mexico, the second-largest U.S. corn ...
Tags: Corn Imports, Food
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing non-toxic DCVax® personalized immune therapies for solid tumor cancers, announced today that the British Broadcasting Company (BBC) TV network ...
Can-Fite BioPharma Ltd. (TASE:CFBI), (NYSE MKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary OphthaliX Inc. (OTCBB:OPLI) ...
Tags: Can-Fite BioPharma, OphthaliX, placebo-controlled phase III study